share_log
Reuters ·  Apr 29 08:30
Atossa Therapeutics Announces Expanded Research Agreement With Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (Adcs) and (Z)-Endoxifen
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment